Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Dmenska, A. Bakula, P. Socha (Warsaw, Poland). Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences. Eur Respir J 2013; 42: Suppl. 57, 415

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Sex differences in alpha-1-antitrypsin deficiency Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Family screening in alpha1-antitrypsin deficiency Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Genetic findings in a family with hereditary spherocytosis, haemolytic anaemia and pulmonary hypertension Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Update on a1-antitrypsin deficiency Source: Breathe, 14 (2) e17; 10.1183/20734735.015018 Year: 2018 Intravenous α1-antitrypsin in a child with deficiency and severe lung disease Source: Eur Respir J 2009; 34: 278-279 Year: 2009 Children’s genetic screening in hereditary haemorrhagic telangiectasia - Read more: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3266 Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017